EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ROIV: Roivant Sciences Ltd

18 Mar 26 04:04
LAST:

28.30

CHANGE:
 0.00		OPEN:
28.30		HIGH:
28.30		ASK:
0.00		VOLUME:
140
CHG(%):
0.00		PREV:
28.30		LOW:
28.30		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 Mar 2628.3028.3028.3028.30140
17 Mar 2628.2128.4728.0228.304.59M
16 Mar 2628.4828.9628.2128.284.59M
13 Mar 2628.8729.2327.9228.065.47M
12 Mar 2629.2329.3528.2728.554.06M
11 Mar 2629.4930.3329.3729.587.33M
10 Mar 2628.9930.3028.9929.705.31M
09 Mar 2628.5929.7628.5129.538.81M
06 Mar 2629.2029.3828.3128.785.69M
05 Mar 2629.6330.0329.0629.729.17M

PROFILE

Name:Roivant Sciences Ltd
About:Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:11-12 St. James's Square, London, United Kingdom, SW1Y 4LB
Website:https://roivant.com
CUSIP:G76279101
CIK:0001635088
ISIN:BMG762791017
FIGI:BBG007STW2B8
LEI:549300DL466NY5J6U724

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:1.95 
Forward P/E:-19.41 
PEG Ratio:-0.01 
Price to Sales:587.56 
Price to Book:3.48 
Profit Margin:0.97 
Operating Margin:-128.40 
Return on Assets:-0.13 
Return on Equity:-0.18 
EPS Ratio:-0.99 
Revenue:23.23M 
Shares:695.49M 
Market Cap:19.682B 

TECHNICAL INDICATORS

MA5:28.300.0%
MA10:28.882.0%
MA20:28.550.9%
MA50:25.5710.7%
MA100:23.1922.1%
MA200:18.0257.1%
STO9:10.57 
STO14:18.15 
RSI14:48.67
WPR14:-75.94
MTM14:-0.64
ROC14:-0.02 
ATR:1.05 
Week High:30.337.2%
Week Low:27.921.4%
Month High:30.337.2%
Month Low:26.7057.1%
Year High:30.337.2%
Year Low:8.73224.2%